Business Strategies
As a leading specialty pharmaceutical Company, Barr focuses its resources
on three principal strategies:
>
developing and marketing select generic
pharmaceuticals;
>
developing and marketing proprietary
pharmaceuticals; and
>
pursuing development and marketing of
generic biologics.
To support its business strategies, the Company continually evaluates acquisition opportunities to strengthen its product portfolio and help grow its business. Barr regularly evaluates opportunities such as strategic
product acquisitions, new technology arrangements including new technology platforms, and
corporate mergers and acquisitions.
Product Guide 
